What is the recommended approach to managing a patient infected with hepatitis C virus who has been on combination interferon and ribavirin therapy and who has developed peripheral neuropathy?

"Alterations in axonal membrane and channel function occur early in the disease course, prior to discernable large fibre involvement, and has the potential to be used as an early biomarker of ...

Fast reversal of electrophysiological blockade after plasmapheresis or intravenous immunoglobulin treatment for acute and chronic inflammatory demyelinating polyneuropathy might reflect removal or ...

As shown in Figure 2, the left peroneal and tibial nerve motor responses were absent, including the left peroneal nerve recorded at the tibialis anterior muscle. In the left arm the median nerve motor ...

Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer. Eight patients developed grade III/IV neurologic motor impairment (predominantly motor axonal ...

Half of patients referred to a specialist centre with a diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) do not actually have the condition, report researchers. Of 58 patients ...

Diabetic Polyneuropathy Not Up With Impaired Glycemia Although significantly increased in subjects with new diabetes, the rates of typical diabetic polyneuropathy (DPN), retinopathy, and nephropathy ...

Abnormal glucose metabolism, which occurs when the body has difficulty processing sugar (glucose) into energy, is twice as common among patients with chronic nerve dysfunction of unknown cause than ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, today announced ...